Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Gainers

• Reata Pharmaceuticals Inc RETA rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
• OncoSec Medical Incorporated ONCS rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
• Lionheart III Corp LION shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
• China Pharma Holdings Inc CPHI rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
• Helbiz Inc HLBZ rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
• Sarepta Therapeutics Inc SRPT rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
• Landos Biopharma Inc LABP shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
• China SXT Pharmaceuticals Inc SXTC rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
• Cerevel Therapeutics Holdings Inc CERE rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
• Bilibili Inc - ADR BILI shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.

Losers

• OKYO Pharma OKYO fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
• Novavax Inc NVAX fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
• Marqeta Inc MQ fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
• Beamr Imaging Ltd. BMR shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
• Obseva SA OBSV shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
• Brightspire Capital Inc BRSP fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
• Performance Shipping Inc PSHG fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
• Grove Collaborative Holdings Inc GROV fell 12.7% to $0.38 in pre-market trading.
• Catalyst Biosciences Inc CBIO fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
• AMC Entertainment Holdings Inc AMC shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.

Now Read This: Top 5 Health Care Stocks That You May Want To Dump In Q1 2023